Novartis Correlations

NVSEF Stock  USD 107.86  1.25  1.17%   
The current 90-days correlation between Novartis AG and Roche Holding AG is 0.02 (i.e., Significant diversification). The correlation of Novartis is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Novartis Correlation With Market

Good diversification

The correlation between Novartis AG and DJI is -0.04 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Novartis AG and DJI in the same portfolio, assuming nothing else is changed.
  
The ability to find closely correlated positions to Novartis could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Novartis when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Novartis - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Novartis AG to buy it.

Moving together with Novartis Pink Sheet

  0.71LLY Eli LillyPairCorr
  0.95JNJ Johnson JohnsonPairCorr
  0.9RHHBF Roche Holding AGPairCorr
  0.94RHHBY Roche HoldingPairCorr
  0.94RHHVF Roche Holding AGPairCorr
  0.93AZN AstraZeneca PLC ADRPairCorr
  0.94NVS Novartis AG ADRPairCorr
  0.91AZNCF AstraZeneca PLCPairCorr
  0.8CTDD Qwest Corp 6PairCorr
  0.81CTBB Qwest Corp NTPairCorr
  0.9RBKB Rhinebeck BancorpPairCorr
  0.88CHKP Check Point SoftwarePairCorr
  0.84ASA ASA Gold Normal TradingPairCorr
  0.63SATS EchoStarPairCorr
  0.88037833DN7 APPLE INCPairCorr
  0.69RBC RBC BearingsPairCorr

Moving against Novartis Pink Sheet

  0.55UHAL-B U Haul HoldingPairCorr
  0.54MRK Merck CompanyPairCorr
  0.38HYMTF Hyundai MotorPairCorr
  0.51DRFS Dr FoodsPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
RHHVFRHHBY
SNYRHHBY
NVSRHHBY
NVSRHHVF
RHHVFRHHBF
BAYZFSNY
  
High negative correlations   
NVSSCLXW
SCLXWRHHBY
SCLXWRHHVF
SCLXWBAYZF
SCLXWSNY
SCLXWAZNCF

Risk-Adjusted Indicators

There is a big difference between Novartis Pink Sheet performing well and Novartis Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Novartis' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
RHHBF  2.32  0.22  0.10 (0.40) 2.72 
 6.60 
 17.19 
AZNCF  1.98  0.18  0.10 (0.78) 2.34 
 3.67 
 18.21 
RHHBY  1.04  0.30  0.27  0.88  0.96 
 2.63 
 5.52 
SNY  1.17  0.29  0.28 (1.69) 0.99 
 2.77 
 10.59 
BMYMP  3.97  0.76  0.10  0.99  4.59 
 12.92 
 41.09 
BAYZF  1.59  0.38  0.24  1.69  1.35 
 4.02 
 12.61 
ALPMF  0.69 (0.04) 0.00 (0.46) 0.00 
 2.11 
 10.41 
RHHVF  1.18  0.30  0.28 (3.88) 1.01 
 2.72 
 6.16 
SCLXW  11.12 (0.18) 0.00  0.18  0.00 
 25.00 
 117.17 
NVS  0.95  0.25  0.25  0.82  0.98 
 2.39 
 7.69 

Be your own money manager

Our tools can tell you how much better you can do entering a position in Novartis without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Options Analysis Now

   

Options Analysis

Analyze and evaluate options and option chains as a potential hedge for your portfolios
All  Next Launch Module

Novartis Corporate Management

Richard SaynorChief SandozProfile
Steffen LangGlobal Head of Novartis Technical Operations, Member of the Executive CommitteeProfile
MarieFrance TschudinPres OfficerProfile
Paul PenepentHead AccountingProfile
Samir MDGlobal RelationsProfile
Robert PharmDChief OfficerProfile
Klaus MoosmayerChief Ethics Risk and Compliance Officer, Member of the Executive CommitteeProfile